Human Ephrin-B3 Biotinylated Antibody
R&D Systems, part of Bio-Techne | Catalog # BAF395
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Biotin
Antibody Source
Polyclonal Goat IgG
Product Specifications
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human Ephrin-B3
Leu28-Ser224
Accession # Q15768
Leu28-Ser224
Accession # Q15768
Specificity
Detects human Ephrin-B3 in Western blots. In Western blots, less than 1% cross-reactivity with recombinant mouse (rm) Ephrin‑A1, rmEphrin‑A2, recombinant human (rh) Ephrin‑A3, rhEphrin‑A4, rhEphrin‑A5, rmEphrin‑B1, and rmEphrin‑B2 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for Human Ephrin-B3 Biotinylated Antibody
Application
Recommended Usage
Western Blot
0.1 µg/mL
Sample: Recombinant Human Ephrin-B3 Fc Chimera (Catalog # 395-EB)
Sample: Recombinant Human Ephrin-B3 Fc Chimera (Catalog # 395-EB)
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Ephrin-B3
References
- Eph Nomenclature Committee [letter]. Cell (1997) 90:403.
- Flanagan, J.G. and P. Vanderhaeghen (1998) Annu. Rev. Neurosci. 21:309.
- Pasquale, E.B. (1997) Curr. Opin. Cell Biol. 9:608.
Alternate Names
EFL-6, Efnb3, Elk-L3, EphrinB3, Epl8, LERK-8, NLERK-2
Gene Symbol
EFNB3
UniProt
Additional Ephrin-B3 Products
Product Documents for Human Ephrin-B3 Biotinylated Antibody
Product Specific Notices for Human Ephrin-B3 Biotinylated Antibody
For research use only
Loading...
Loading...
Loading...
Loading...